Table 3 Cost- effectiveness of HS nebulized vs Control group
From: The cost-utility of early use of high-flow nasal cannula in bronchiolitis
Strategy | Cost (US$) | Difference | QALYs | Difference | Cost/QALY | ICER |
|---|---|---|---|---|---|---|
HFNC | $ 368,89 | 0,91 | 403,55 | |||
Control | $ 441,37 | −72.46 | 0,91 | 0,004 | 484,75 | (Dominated) |